Skip to content

Depression: all studies

Page 456 of 1,034: studies 4,551 to 4,560 of 10,336, newest first. Back to the depression overview

Research

The Role of Self-Compassion in Conscious Connected Breathing: Evidence from a Randomized Controlled Trial

Open Mind July 9, 2026 Emma Wiethoff, Barbara Breitenstein, Nina Hartter et al. preprint

This preregistration specifies hypotheses and an analysis plan for a randomized controlled trial comparing Conscious Connected Breathing (CCB) with Progressive Muscle Relaxation (PMR) in adults with a history of childhood adversity. The primary outcome is change in self-compassion from pre- to post-intervention. Secondary analyses examine whether altered states of consciousness during CCB...

Psychedelics and the thalamocortical system: A scoping review

Pharmacology, Biochemistry, and Behavior July 9, 2026 Sofía Villalba, Agustín Martínez Christensen, Lucia di Costanzo et al.

In recent years, psychedelics have shown promising results as therapeutic interventions for individuals with depression, terminal illnesses, substance use disorder, neurodegenerative diseases, trauma and obsessive-compulsive disorder. Moreover, research involving psychedelics have contributed to the understanding of the neurobiological mechanisms behind the "psychedelic state of consciousness"...

DOI: 10.1016/j.pbb.2026.174232 (opens in new tab) Serotonin Thalamus Pathological Clinical practice +2

Efficacy and safety of perioperative esketamine for postoperative depressive symptoms in breast cancer patients: a meta-analysis

Frontiers in Pharmacology July 8, 2026 Ruoyi Ji, Xinyuan Shi, X Q Liu et al.

Background: Postoperative depressive symptoms may impair recovery and quality of life in patients undergoing breast cancer surgery. Esketamine has shown potential antidepressant and analgesic effects in the perioperative setting. This meta-analysis evaluated the efficacy and safety of perioperative esketamine for postoperative depressive symptoms in patients undergoing breast cancer surgery....

Efficacy comparison of mindfulness-based cognitive therapy and routine support on anxiety and sleep quality in peritoneal dialysis patients

World Journal of Psychiatry July 8, 2026 Yu-Peng Liu, Chen-Chen Shen, Jing Li et al.

BACKGROUND Patients undergoing peritoneal dialysis (PD) frequently experience anxiety and sleep disturbances.However, the comparative efficacy of psychological interventions on these symptoms remains unclear.AIM To compare the efficacy of mindfulness-based cognitive therapy (MBCT) and routine psychological support (PS) on anxiety symptoms and sleep quality in patients undergoing PD.METHODS This...

DOI: 10.5498/wjp.122241 (opens in new tab) Anxiety Sleep quality Peritoneal dialysis Sleep system call +7

Zoletil 50-induced mental and behavioral abnormalities: a case report and literature review

Frontiers in Psychology July 8, 2026 Yuanji Liu, S W Wang

Background Zoletil 50, mixed with tiletamine and zolazepam, a veterinary anesthetic, has increasingly been used as a substitute drug by substance abusers in recent years. Recently, it has been found in China that tiletamine has been added to electronic cigarettes as a stimulant, highlighting the need for further evaluation of its safety. Case presentation A 22-year-old, previously healthy,...

DOI: 10.3389/fpsyg.2026.1884471 (opens in new tab) Feeling Panic Presentation obstetrics Recreation +5

Convergent increases in serotonin 1B receptor binding following ketamine and electroconvulsive therapy: a multi-centre bayesian re-analysis of PET data

Molecular Psychiatry July 8, 2026 Granville J. Matheson, Johan Lundberg, Martin Gärde et al.

The serotonin 1B receptor can be studied in vivo with PET using [^11C]AZ10419369, and has been linked to both the pathophysiology and treatment of major depressive disorder (MDD). Ketamine and electroconvulsive therapy (ECT) both exert rapid and potent antidepressive effects, and although these treatments may not act directly on the serotonin system, they both cause dose-dependent increases in...

Yoga Nidra Versus Music Therapy for Sleep and Mental Well-being in Post-COVID-19 Hospitalised Patients: A Three-arm Randomised Controlled Trial

Annals of Neurosciences July 7, 2026 Vikram Jain, Monika Pathania, Prasan Kumar Panda et al.

Background The COVID-19 pandemic has resulted in a significant increase in mental health issues, including depression, anxiety, post-traumatic stress disorder and sleep disturbances, particularly among recently hospitalised patients. Non-pharmacological interventions such as Yoga Nidra and Music Therapy offer cost-effective and accessible alternatives for improving psychological well-being and...

DOI: 10.1177/09727531261451357 (opens in new tab) Music therapy Randomized controlled trial Psychological intervention Mental health +3

Sex-specific electrophysiological and behavioral responses to nitrous oxide in a murine model of neuropathic pain.

Biology of Sex Differences July 7, 2026 Gemma González-Hernández, S. Torres-Sánchez, D. Sanchez-Morillo et al.

Chronic pain-depression comorbidity is characterized by sensory hypersensitivity and emotional dysregulation, and has been linked to alterations in prefrontal network connectivity. It represents a major therapeutic challenge due to its pronounced sex differences in symptom manifestation and increased treatment resistance. Nitrous oxide (N₂O), an inhalational anesthetic traditionally used for...

A multiple methods pilot study of the Mindfulness and Self‐Compassion for Children and Caregivers course

Family Relations July 6, 2026 Christine Lathren, S. DiMaio, Hana Nip et al.

This multiple methods study examines the feasibility, acceptability, and preliminary outcomes associated with participation in the Mindfulness and Self‐Compassion for Children and Caregivers course (MSC‐CC). School‐age youth are experiencing unprecedented levels of anxiety and depression. Self‐compassion skills are accessible, evidence‐based, transdiagnostic tools that can help children...

Intravenous Ketamine in Psychiatry: Therapeutic Applications, Mechanisms of Action, and Clinical Perspectives

Open Minds International Journal July 6, 2026 Juliana Leite Haubman, João Octávio Celante da Silva, Bruno Horta Leonardo Machado de Moura et al.

Intravenous esketamine represents a significant therapeutic innovation in the field of psychiatry, particularly in the management of treatment-resistant depression and severe psychiatric conditions associated with suicidal ideation.Derived from the S-enantiomer of ketamine, esketamine acts primarily as an N-methyl-D-aspartate (NMDA) receptor antagonist, promoting rapid glutamatergic modulation...